Centiva Capital’s Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HTPA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-19,499
Closed -$24K 1823
2021
Q1
$24K Buy
+19,499
New +$33.3K ﹤0.01% 1101

Other funds holding HTPA.WS

Centiva Capital's HTPA.WS Position: Q2 2021 in Review

Centiva Capital sold out of Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HTPA.WS) in Q2 2021, closing a stake of 19,499 shares — an estimated $24K sold.

Centiva Capital first reported a position in HTPA.WS in Q1 2021 and held it in 1 quarter. The position peaked at $24K in Q1 2021. 31 funds tracked by Wall St. Rank hold HTPA.WS as of Q2 2021.

  • Centiva Capital reported no remaining Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 19,499 Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2021, an estimated $24K.
  • Centiva Capital first reported a position in Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 1 quarter.
  • Centiva Capital's Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $24K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.